Empowering Clinical Trial
Development Teams

Discover causal insights with Attractor AI for smarter clinical trial decisions

;

Introducing The
NetraAI Lab

A Next Generation AI Solution Revolutionizing Clinical Trials

Unlock the potential of your clinical trials through a novel AI solution.

Effortlessly generate and decipher insights on treatment efficacy, toxicity, and placebo response

Introducing NetraAI: Know Your Patients

NetraAI is built to uncover the hidden relationship between patients in your clinical trial by using novel methods and empowering scientists to make critical decisions

NetraAI, powered by Attractor AI, a proprietary long-range attractor algorithm, deciphers hidden patient correlations in your clinical trials, providing optimal causal factors with exceptional clarity and explainability.

Introducing NetraAI: Know Your Disease

Unlock the factors behind the heterogeneity of your patient population with our technology. Use these high dimensional views to enhance enrichment, reducing clinical trial risks and fostering success. Avoid populations that can hinder your development early on

Introducing NetraAI: Design Smarter Patient-

Centric Protocols With Intelligence

NetraAI generates insights that drastically improve inclusion/exclusion criteria leading to larger effect sizes and lower p values. Find the maximum population that is likely to be responsive. Make phase III studies smaller and more efficient

Publications, White Papers & Posters

Small Patient Datasets Reveal Genetic Drivers of Non-Small Cell Lung Cancer Subtypes using a Novel Machine For Hypothesis Generation

July 26, 2023 | Moses Cook, Bessi Qorri, Amruth Baskar, Jalal Ziauddin, Luca Pani, Shashi Bushan Yenkanchi, Joseph Geraci

Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials

January – March 2022 | Erica A. Smith, William P. Horan, Dominique Demolle, Peter Schueler, Dong-Jing Fu, Ariana E. Anderson, Joseph Geraci, Florence Butlen-Ducuing, Jasmine Link, Ni A. Khin, Robert Morlock, & Larry D. Alphs

Using machine intelligence to uncover Alzheimer’s disease progression heterogeneity

December, 31 2020 | Bessi Qorri, Mike Tsay, Abhishek Agrawal, Rhoda Au, & Joseph Geraci

Disrupting the Aging Process

Jan 2019 | Stephan Boissonneault

Next-Gen AI for Disease Definition, Patient Stratification, and Placebo Effect

21 July 2020 | Mike Tsay, Joseph Geraci, Abhishek Agrawal

Evaluation of postmortem microarray data in bipolar disorder using traditional data comparison and artificial intelligence reveals novel gene targets

October 2021 | Jaehyoung Choi, David F. Bodenstein, Joseph Geraci, & Ana C. Andreazza

Shattering cancer with quantum machine learning: A preview

11 Jun 2021| Joseph Geraci

Quantum and classical machine learning for the classification of non-small-cell lung cancer patients

16 May 2020 | Siddhant Jain, Jalal Ziauddin, Paul Leonchyk, Shashibushan Yenkanchi & Joseph Geraci

Attractor AI Provides Machine Learning Algorithms With The Power Of Causal Inference Through An Innovative Look-Back Memory Technology

Our Products

Netra AI

NetraAI decodes the complexities of patient populations, offering invaluable insights to clinical trial professionals. It enhance the efficiency and reliability of clinical trials. To achieve this, it harnesses the power of cutting-edge Attractor-based technology, capable of discerning the unique combinations of variables that define patient characteristics.

Netra AI

NetraAI decodes the complexities of patient populations, offering invaluable insights to clinical trial professionals. It enhance the efficiency and reliability of clinical trials. To achieve this, it harnesses the power of cutting-edge Attractor-based technology, capable of discerning the unique combinations of variables that define patient characteristics.

Netra Placebo

NetraPlacebo pinpoints the patients in your trial who are eliciting the placebo response, and the reasons why. By combining attitudinal and psychological data, alongside information from previous trials, NetraPlacebo constructs a model that identifies the factors propelling both the placebo and drug response, enabling optimal trial enrichment allowing inclusion/exclusion criteria adjustments without adversely affecting your drug’s response and maximizing separation

Netra GPT

NetraGPT adds additional explainability to NetraAI’s Attractor-based technology, augmenting these signals with the robust abilities of Large Language Models. The multidimensional patient profiling is further enhanced through the perspective of extensive medical and scientific literature.

Meet The Founder

Dr Joseph Geraci, Ph.D. is a mathematician, medical scientist, and quantum machine learning specialist. He holds postdocs in artificial intelligence, oncology, and neuropsychiatry. He has developed novel machine intelligence algorithms that are capable of providing extraordinary insights into small complex data sets, like those found in clinical trials.

He is associated with the department of Molecular Medicine and Pathology at Queen’s University in Ontario, Canada and the Centre for Biotechnology and Genomics Medicine Medical College of Georgia, USA, and is a visiting scientist in quantum computation and neuroscience at the University of California, San Diego.

Get In Touch To Learn How Our Products Can Help Your Business